Advisory Board on Radiation and Worker Health (ABRWH), Subcommittee for Dose Reconstruction Reviews (SDRR), National Institute for Occupational Safety and Health (NIOSH), 67711 [2021-25863]
Download as PDF
<![CDATA[
Federal Register / Vol. 86, No. 226 / Monday, November 29, 2021 / Notices
device, or any other electronic or
mechanical device designed for similar
purposes is prohibited at ASC Meetings.
James R. Park,
Executive Director.
[FR Doc. 2021–25860 Filed 11–26–21; 8:45 am]
BILLING CODE 6700–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Board on Radiation and
Worker Health (ABRWH),
Subcommittee for Dose
Reconstruction Reviews (SDRR),
National Institute for Occupational
Safety and Health (NIOSH)
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:
In accordance with the
Federal Advisory Committee Act, the
CDC announces the following meeting
for the Subcommittee for Dose
Reconstruction Reviews (SDRR) of the
Advisory Board on Radiation and
Worker Health (ABRWH or the Advisory
Board). This meeting is open to the
public, but without a public comment
period. The public is welcome to submit
written comments in advance of the
meeting, to the contact person below.
Written comments received in advance
of the meeting will be included in the
official record of the meeting. The
public is also welcomed to listen to the
meeting by joining the audio conference
(information below). The audio
conference line has 150 ports for callers.
DATES: The meeting will be held on
January 19, 2022, from 10:30 a.m. to
4:00 p.m., EST.
Written comments must be received
on or before January 12, 2022.
ADDRESSES: You may submit comments
by mail to: Sherri Diana, National
Institute for Occupational Safety and
Health, 1090 Tusculum Avenue, MS C–
34, Cincinnati, Ohio 45226. Meeting
Information: Audio Conference Call via
FTS Conferencing. The USA toll-free
dial-in number is 1–866–659–0537; the
pass code is 9933701.
FOR FURTHER INFORMATION CONTACT:
Rashaun Roberts, Ph.D., Designated
Federal Officer, NIOSH, CDC, 1090
Tusculum Avenue, Mailstop C–24,
Cincinnati, Ohio 45226, Telephone:
(513) 533–6800; Toll Free 1(800) CDC–
INFO; Email: ocas@cdc.gov.
SUPPLEMENTARY INFORMATION:
khammond on DSKJM1Z7X2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
16:55 Nov 26, 2021
Jkt 256001
Background: The Advisory Board was
established under the Energy Employees
Occupational Illness Compensation
Program Act of 2000 to advise the
President on a variety of policy and
technical functions required to
implement and effectively manage the
new compensation program. Key
functions of the Advisory Board include
providing advice on the development of
probability of causation guidelines that
have been promulgated by the
Department of Health and Human
Services (HHS) as a final rule; advice on
methods of dose reconstruction, which
have also been promulgated by HHS as
a final rule; advice on the scientific
validity and quality of dose estimation
and reconstruction efforts being
performed for purposes of the
compensation program; and advice on
petitions to add classes of workers to the
Special Exposure Cohort (SEC). In
December 2000, the President delegated
responsibility for funding, staffing, and
operating the Advisory Board to HHS,
which subsequently delegated this
authority to CDC. NIOSH implements
this responsibility for CDC.
The Advisory Board’s charter was
issued on August 3, 2001, renewed at
appropriate intervals, and rechartered
under Executive Order 13889 on March
22, 2020, and will terminate on March
22, 2022.
Purpose: The Advisory Board is
charged with (a) providing advice to the
Secretary, HHS, on the development of
guidelines under Executive Order
13179; (b) providing advice to the
Secretary, HHS, on the scientific
validity and quality of dose
reconstruction efforts performed for this
program; and (c) upon request by the
Secretary, HHS, advise the Secretary on
whether there is a class of employees at
any Department of Energy facility who
were exposed to radiation but for whom
it is not feasible to estimate their
radiation dose, and on whether there is
reasonable likelihood that such
radiation doses may have endangered
the health of members of this class.
SDRR was established to aid the
Advisory Board in carrying out its duty
to advise the Secretary, HHS, on dose
reconstruction.
Matters to be Considered: The agenda
will include discussions on the
following dose reconstruction program
quality management and assurance
activities: Dose reconstruction cases
under review from Sets 29 and 30,
possibly including cases involving:
Nevada test Site, Oak Ridge Institute for
Science Education, Rocky Flats Plant,
Idaho National Laboratory, Y–12 Plant,
Clarksville Modification Center, Pantex
Plant, Oak Ridge National Laboratory
PO 00000
Frm 00038
Fmt 4703
Sfmt 4703
67711
(X–10), Albuquerque Operations Office,
General Atomics, Area IV of the Santa
Susanna Field Laboratory, Oak Ridge
Gaseous Diffusion Plant (K–25),
Savannah River Site (SRS), Hanford,
SRS, X–10, Y–12 Plant, and General
Steel Industries. Agenda items are
subject to change as priorities dictate.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2021–25863 Filed 11–26–21; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Submission for OMB Review;
Understanding the Value of Centralized
Services Study (New Collection)
Office of Planning, Research,
and Evaluation, Administration for
Children and Families, HHS.
ACTION: Request for public comment.
AGENCY:
The Administration for
Children and Families (ACF), U.S.
Department of Health and Human
Services (HHS) is proposing a new data
collection activity as part of the
Understanding the Value of Centralized
Services study. The objective of this
descriptive study is to understand the
advantages, disadvantages, and costs of
centralizing services for individuals and
families with low incomes.
DATES: Comments due within 30 days of
publication. OMB must make a decision
about the collection of information
between 30 and 60 days after
publication of this document in the
Federal Register. Therefore, a comment
is best assured of having its full effect
if OMB receives it within 30 days of
publication.
ADDRESSES: Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
PRAMain. Find this particular
information collection by selecting
SUMMARY:
E:\FR\FM\29NON1.SGM
29NON1
]]>Agencies
[Federal Register Volume 86, Number 226 (Monday, November 29, 2021)]
[Notices]
[Page 67711]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-25863]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Advisory Board on Radiation and Worker Health (ABRWH),
Subcommittee for Dose Reconstruction Reviews (SDRR), National Institute
for Occupational Safety and Health (NIOSH)
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC
announces the following meeting for the Subcommittee for Dose
Reconstruction Reviews (SDRR) of the Advisory Board on Radiation and
Worker Health (ABRWH or the Advisory Board). This meeting is open to
the public, but without a public comment period. The public is welcome
to submit written comments in advance of the meeting, to the contact
person below. Written comments received in advance of the meeting will
be included in the official record of the meeting. The public is also
welcomed to listen to the meeting by joining the audio conference
(information below). The audio conference line has 150 ports for
callers.
DATES: The meeting will be held on January 19, 2022, from 10:30 a.m. to
4:00 p.m., EST.
Written comments must be received on or before January 12, 2022.
ADDRESSES: You may submit comments by mail to: Sherri Diana, National
Institute for Occupational Safety and Health, 1090 Tusculum Avenue, MS
C-34, Cincinnati, Ohio 45226. Meeting Information: Audio Conference
Call via FTS Conferencing. The USA toll-free dial-in number is 1-866-
659-0537; the pass code is 9933701.
FOR FURTHER INFORMATION CONTACT: Rashaun Roberts, Ph.D., Designated
Federal Officer, NIOSH, CDC, 1090 Tusculum Avenue, Mailstop C-24,
Cincinnati, Ohio 45226, Telephone: (513) 533-6800; Toll Free 1(800)
CDC-INFO; Email: [email protected].
SUPPLEMENTARY INFORMATION:
Background: The Advisory Board was established under the Energy
Employees Occupational Illness Compensation Program Act of 2000 to
advise the President on a variety of policy and technical functions
required to implement and effectively manage the new compensation
program. Key functions of the Advisory Board include providing advice
on the development of probability of causation guidelines that have
been promulgated by the Department of Health and Human Services (HHS)
as a final rule; advice on methods of dose reconstruction, which have
also been promulgated by HHS as a final rule; advice on the scientific
validity and quality of dose estimation and reconstruction efforts
being performed for purposes of the compensation program; and advice on
petitions to add classes of workers to the Special Exposure Cohort
(SEC). In December 2000, the President delegated responsibility for
funding, staffing, and operating the Advisory Board to HHS, which
subsequently delegated this authority to CDC. NIOSH implements this
responsibility for CDC.
The Advisory Board's charter was issued on August 3, 2001, renewed
at appropriate intervals, and rechartered under Executive Order 13889
on March 22, 2020, and will terminate on March 22, 2022.
Purpose: The Advisory Board is charged with (a) providing advice to
the Secretary, HHS, on the development of guidelines under Executive
Order 13179; (b) providing advice to the Secretary, HHS, on the
scientific validity and quality of dose reconstruction efforts
performed for this program; and (c) upon request by the Secretary, HHS,
advise the Secretary on whether there is a class of employees at any
Department of Energy facility who were exposed to radiation but for
whom it is not feasible to estimate their radiation dose, and on
whether there is reasonable likelihood that such radiation doses may
have endangered the health of members of this class. SDRR was
established to aid the Advisory Board in carrying out its duty to
advise the Secretary, HHS, on dose reconstruction.
Matters to be Considered: The agenda will include discussions on
the following dose reconstruction program quality management and
assurance activities: Dose reconstruction cases under review from Sets
29 and 30, possibly including cases involving: Nevada test Site, Oak
Ridge Institute for Science Education, Rocky Flats Plant, Idaho
National Laboratory, Y-12 Plant, Clarksville Modification Center,
Pantex Plant, Oak Ridge National Laboratory (X-10), Albuquerque
Operations Office, General Atomics, Area IV of the Santa Susanna Field
Laboratory, Oak Ridge Gaseous Diffusion Plant (K-25), Savannah River
Site (SRS), Hanford, SRS, X-10, Y-12 Plant, and General Steel
Industries. Agenda items are subject to change as priorities dictate.
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2021-25863 Filed 11-26-21; 8:45 am]
BILLING CODE 4163-18-P
